InvestorsHub Logo
Followers 827
Posts 119468
Boards Moderated 15
Alias Born 09/05/2002

Re: alternatepatel post# 17219

Friday, 05/12/2017 9:36:13 AM

Friday, May 12, 2017 9:36:13 AM

Post# of 20689
ABBV's '135 patent is pretty important insofar it could block approval of an FoB in RA, specifically, which is Humira's biggest indication. However, I'm confident that the '135 patent will be found invalid—if not by the USPTO then by the CAFC (on appeal).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”